Financial statements Apteka Vademecum
Balance sheet of Apteka Vademecum
Company age:
Age:
18 y. 5 m. 27 d.
Share capital:
Share capital:
50 000 PLN
Balance sheet data of APTEKA VADEMECUM
|
Year
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 569 486,92 | 740 451,15 | 923 778,28 | 1 434 437,28 | 1 734 496,26 |
| A. Fixed assets | 45 568,95 | 38 081,56 | 30 594,17 | 923 106,78 | 916 198,85 |
| B. Current assets | 523 917,97 | 702 369,59 | 893 184,11 | 511 330,50 | 818 297,41 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 569 486,92 | 740 451,15 | 923 778,28 | 1 434 437,28 | 1 734 496,26 |
| A. Equity | 380 030,17 | 562 112,91 | 725 913,64 | 1 056 219,39 | 1 370 356,12 |
| B. Liabilities and provisions for liabilities | 189 456,75 | 178 338,24 | 197 864,64 | 378 217,89 | 364 140,14 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 194 519,75 | 127 859,75 |
| II. Short-term liabilities | 189 456,75 | 178 338,24 | 197 864,64 | 183 698,14 | 236 280,39 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.